Blink Device Company Celebrates Record-Breaking Year with Gratitude to Customers and Colleagues

Seattle, WA January 1, 2025 – Blink Device Company extends its heartfelt gratitude to our exceptional customers and colleagues worldwide for making 2024 another record-breaking year! We are excited to share key achievements that demonstrate our commitment to advancing quantitative neuromuscular monitoring through innovation. 

• Investment in Research and Development: We have tripled the size of our engineering team to accelerate development of our TwitchView® product pipeline, positioning ourselves to meet the evolving needs of our customers and sustain our commitment to innovation in patient safety. 

• Expansion of Sales and Clinical Team: Our field team has more than doubled in size, enabling us to meet increasing demand from new hospitals while continuing to provide comprehensive training and support to our existing clinical partners.   

• Global Reach: We have substantially expanded our global presence, enabling us to better serve a broader community of healthcare professionals. 

• Remarkable Growth in Pediatric Population: Our pediatric electrode sales have surged by an astonishing 500%, underscoring our customer’s commitment to improving pediatric care and validating our investment in creating a reliable system for quantitative monitoring in this difficult-to-monitor population. 

• Top Hospitals Partnership: We are proud to add to our customer base 12 more of the Top 100 U.S. Hospitals and their affiliated systems, affirming the trust placed in our products by leading healthcare institutions. 

• Data Integration: Over 90% of our customers have successfully integrated TwitchView® Systems data into their electronic health records. This integration reinforces TwitchView® quantitative monitoring as a standard of care, improving the management of neuromuscular blocking drugs and leading to better patient outcomes.   

“As we celebrate these significant milestones, we reaffirm our commitment to providing quantitative neuromuscular monitoring solutions that clinicians trust and rely on,” stated CEO Justin Hulvershorn, MD, PhD. “Our success is a reflection of the support of our customers, their commitment to improving patient care, and to the hard work of our outstanding team.”